| 1. | oxbum49791 | |
| 2. | latinoboyz4874 | |
| 3. | MamisTrist | |
| 4. | rpereira07 | |
| 5. | franklola4509 |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | WalkingDeader 01/22/2018 Novartis completes tender offer for Advanced Accelerator Applications S.A. and announces commencement of subsequent offering period |
| 2. | 813kimd 02/18/2018 Novartis AG is preparing to sell its U.S. generic pill business, |
| 3. | WalkingDeader 01/26/2018 UPGRADES SOON - Reports of EPS beat ranging from $0.02 to $0.04. Beats on revenues. |
| 4. | sonhinchie 05/15/2018 Novartis completes tender offer for all outstanding shares of AveXis, Inc. |
| 5. | oxbum49791 01/18/2018 Superiority of Cosentyx® versus Stelara®* in achieving skin clearance for psoriasis patients |
| 6. | rpereira07 01/25/2018 Wow!! ... More Awesome news for $NVS |
| 7. | MamisTrist 01/22/2018 Good stuff! |
| 8. | boxerrunner27 03/26/2018 Phase III data in The Lancet show Novartis siponimod significantly improves outcomes in patients with secondary progressive MS |
| 9. | rpereira07 07/27/2018 Confirms the EMA's CHMP adopted a positive opinion recommending approval of Tafinlar |
| 10. | MamisTrist 02/14/2018 Novartis forms alliance to develop medicines for treating infectious diarrheal disease |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Novartis AG
- NVS
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.